started · updated
Portuguese technology identifies antibiotic-resistant bacteria in 45 minutes
A consortium of Portuguese companies, universities, and research centers has developed InviDx, a technology capable of identifying bacteria and genes associated with antibiotic resistance in approximately 45 minutes. Developed under the SMARTgNOSTICS project, the device can detect up to ten different targets in a urine sample.
Currently, standard laboratory methods such as urine cultures can take between 48 and 72 hours to identify bacteria responsible for urinary tract infections and assess antibiotic sensitivity. InviDx utilizes molecular analysis to identify the genetic material of microorganisms and their resistance mechanisms, bypassing the need to wait for bacteria to multiply in a laboratory setting.
While the technology offers significant speed advantages, the identification of resistance genes does not automatically determine the most appropriate antibiotic for a patient. Results require interpretation by healthcare professionals and may need supplementation with additional tests. At present, InviDx is available for research purposes only and has not yet received authorization as a clinical diagnostic device. The first approved clinical study will be conducted at the Unidade Local de Saúde da Cova da Beira in Portugal, focusing on urinary tract infections. The consortium aims to expand the platform to identify agents related to sepsis, respiratory infections, and sexually transmitted infections in the future.
Entities
InviDx · Portugal · SMARTgNOSTICS · Unidade Local de Saúde da Cova da Beira